141 related articles for article (PubMed ID: 27869315)
1. Aminoalkyl Derivatives of 8-Alkoxypurine-2,6-diones: Multifunctional 5-HT
Chłoń-Rzepa G; Zagórska A; Żmudzki P; Bucki A; Kołaczkowski M; Partyka A; Wesołowska A; Kazek G; Głuch-Lutwin M; Siwek A; Starowicz G; Pawłowski M
Arch Pharm (Weinheim); 2016 Dec; 349(12):889-903. PubMed ID: 27869315
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of 2-fluoro and 3-trifluoromethyl-phenyl-piperazinylalkyl derivatives of 1H-imidazo[2,1-f]purine-2,4(3H,8H)-dione as potential antidepressant agents.
Zagórska A; Bucki A; Kołaczkowski M; Siwek A; Głuch-Lutwin M; Starowicz G; Kazek G; Partyka A; Wesołowska A; Słoczyńska K; Pękala E; Pawłowski M
J Enzyme Inhib Med Chem; 2016; 31(sup3):10-24. PubMed ID: 27353547
[TBL] [Abstract][Full Text] [Related]
3. New 8-aminoalkyl derivatives of purine-2,6-dione with arylalkyl, allyl or propynyl substituents in position 7, their 5-HT1A, 5-HT2A, and 5-HT7 receptor affinity and pharmacological evaluation.
Chłoń-Rzepa G; Zmudzki P; Satała G; Duszyńska B; Partyka A; Wróbel D; Jastrzębska-Więsek M; Wesołowska A; Bojarski AJ; Pawłowski M; Zajdel P
Pharmacol Rep; 2013; 65(1):15-29. PubMed ID: 23563020
[TBL] [Abstract][Full Text] [Related]
4. New 1-aryl-3-(4-arylpiperazin-1-yl)propane derivatives, with dual action at 5-HT1A serotonin receptors and serotonin transporter, as a new class of antidepressants.
Martínez-Esparza J; Oficialdegui AM; Pérez-Silanes S; Heras B; Orús L; Palop JA; Lasheras B; Roca J; Mourelle M; Bosch A; Del Castillo JC; Tordera R; Del Río J; Monge A
J Med Chem; 2001 Feb; 44(3):418-28. PubMed ID: 11462981
[TBL] [Abstract][Full Text] [Related]
5. New arylpiperazinylalkyl derivatives of 8-alkoxy-purine-2,6-dione and dihydro[1,3]oxazolo[2,3-f]purinedione targeting the serotonin 5-HT1A /5-HT2A /5-HT7 and dopamine D2 receptors.
Chłoń-Rzepa G; Zagórska A; Bucki A; Kołaczkowski M; Pawłowski M; Satała G; Bojarski AJ; Partyka A; Wesołowska A; Pękala E; Słoczyńska K
Arch Pharm (Weinheim); 2015 Apr; 348(4):242-53. PubMed ID: 25773907
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationship studies of CNS agents, Part 31: Analogs of MP 3022 with a different number of nitrogen atoms in the heteroaromatic fragment--new 5-HT1A receptor ligands.
Paluchowska MH; Dereń-Wesołek A; Mokrosz JL; Charakchieva-Minol S; Chojnacka-Wójcik E
Arch Pharm (Weinheim); 1996 Oct; 329(10):451-6. PubMed ID: 8933747
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationships and molecular studies of novel arylpiperazinylalkyl purine-2,4-diones and purine-2,4,8-triones with antidepressant and anxiolytic-like activity.
Zagórska A; Kołaczkowski M; Bucki A; Siwek A; Kazek G; Satała G; Bojarski AJ; Partyka A; Wesołowska A; Pawłowski M
Eur J Med Chem; 2015 Jun; 97():142-54. PubMed ID: 25965777
[TBL] [Abstract][Full Text] [Related]
8. The impact of the halogen bonding on D
Partyka A; Kurczab R; Canale V; Satała G; Marciniec K; Pasierb A; Jastrzębska-Więsek M; Pawłowski M; Wesołowska A; Bojarski AJ; Zajdel P
Bioorg Med Chem; 2017 Jul; 25(14):3638-3648. PubMed ID: 28529043
[TBL] [Abstract][Full Text] [Related]
9. 7-3-Chlorophenypiperazinylalkyl derivatives of 8-alkoxy-purine-2,6-dione as a serotonin receptor ligands with potential antidepressant activity.
Zygmunt M; Sapa J; Chłoń-Rzepa G; Zagórska A; Siwek A; Pawłowski M; Nowak G
Pharmacol Rep; 2014 Jun; 66(3):505-10. PubMed ID: 24905531
[TBL] [Abstract][Full Text] [Related]
10. Novel anilide and benzylamide derivatives of arylpiperazinylalkanoic acids as 5-HT
Jankowska A; Satała G; Kołaczkowski M; Bucki A; Głuch-Lutwin M; Świerczek A; Pociecha K; Partyka A; Jastrzębska-Więsek M; Lubelska A; Latacz G; Gawalska A; Bojarski AJ; Wyska E; Chłoń-Rzepa G
Eur J Med Chem; 2020 Sep; 201():112437. PubMed ID: 32673902
[TBL] [Abstract][Full Text] [Related]
11. 5-HT1A and 5-HT2A receptor affinity and functional profile of some N-[3-(4-aryl-1-piperazinyl)propyl] derivatives of indolin-2(1H)-one, quinolin-2(1 H)-one and isoquinolin-1(2H)-one. Part 30: Structure-activity relationship studies of CNS agents.
Mokrosz MJ; Mokrosz JL; Duszyńska B; Dereń-Wesołek A; Kłodzińska A; Kowalski P; Charakchieva-Minol S; Tatarczyńska E; Kowalska T; Majka Z; Chojnacka-Wójcik E; Misztal S
Pharmazie; 1997 Jun; 52(6):423-8. PubMed ID: 9260266
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antidepressant-like activity of novel aralkyl piperazine derivatives targeting SSRI/5-HT
Gu ZS; Zhou AN; Xiao Y; Zhang QW; Li JQ
Eur J Med Chem; 2018 Jan; 144():701-715. PubMed ID: 29291438
[TBL] [Abstract][Full Text] [Related]
13. Towards novel 5-HT7versus 5-HT1A receptor ligands among LCAPs with cyclic amino acid amide fragments: design, synthesis, and antidepressant properties. Part II.
Canale V; Kurczab R; Partyka A; Satała G; Witek J; Jastrzębska-Więsek M; Pawłowski M; Bojarski AJ; Wesołowska A; Zajdel P
Eur J Med Chem; 2015 Mar; 92():202-11. PubMed ID: 25555143
[TBL] [Abstract][Full Text] [Related]
14. HBK-14 and HBK-15 with antidepressant-like and/or memory-enhancing properties increase serotonin levels in the hippocampus after chronic treatment in mice.
Pytka K; Gawlik K; Pawlica-Gosiewska D; Witalis J; Waszkielewicz A
Metab Brain Dis; 2017 Apr; 32(2):547-556. PubMed ID: 27888375
[TBL] [Abstract][Full Text] [Related]
15. New 3-[4-(aryl)piperazin-1-yl]-1-(benzo[b]thiophen-3-yl)propane derivatives with dual action at 5-HT1A serotonin receptors and serotonin transporter as a new class of antidepressants.
Martínez J; Pérez S; Oficialdegui AM; Heras B; Orús L; Villanueva H; Palop JA; Roca J; Mourelle M; Bosch A; Del Castillo JC; Lasheras B; Tordera R; del Río J; Monge A
Eur J Med Chem; 2001 Jan; 36(1):55-61. PubMed ID: 11231049
[TBL] [Abstract][Full Text] [Related]
16. Computer-aided insights into receptor-ligand interaction for novel 5-arylhydantoin derivatives as serotonin 5-HT
Kucwaj-Brysz K; Kurczab R; Jastrzębska-Więsek M; Żesławska E; Satała G; Nitek W; Partyka A; Siwek A; Jankowska A; Wesołowska A; Kieć-Kononowicz K; Handzlik J
Eur J Med Chem; 2018 Mar; 147():102-114. PubMed ID: 29425815
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and pharmacological evaluation of new arylpiperazines. 3-[4-[4-(3-chlorophenyl)-1-piperazinyl]butyl]-quinazolidin-4-one - a dual serotonin 5-HT(1A)/5-HT(2A) receptor ligand with an anxiolytic-like activity.
Bojarski AJ; Kowalski P; Kowalska T; Duszyńska B; Charakchieva-Minol S; Tatarczyńska E; Kłodzińska A; Chojnacka-Wójcik E
Bioorg Med Chem; 2002 Dec; 10(12):3817-27. PubMed ID: 12413835
[TBL] [Abstract][Full Text] [Related]
18. Antidepressant- and anxiolytic-like activity of 7-phenylpiperazinylalkyl-1,3-dimethyl-purine-2,6-dione derivatives with diversified 5-HT₁A receptor functional profile.
Partyka A; Chłoń-Rzepa G; Wasik A; Jastrzębska-Więsek M; Bucki A; Kołaczkowski M; Satała G; Bojarski AJ; Wesołowska A
Bioorg Med Chem; 2015 Jan; 23(1):212-21. PubMed ID: 25435254
[TBL] [Abstract][Full Text] [Related]
19. New arylpiperazine 5-HT(1A) receptor ligands containing the pyrimido[2,1-f]purine fragment: synthesis, in vitro, and in vivo pharmacological evaluation.
Jurczyk S; Kołaczkowski M; Maryniak E; Zajdel P; Pawłowski M; Tatarczyńska E; Kłodzińska A; Chojnacka-Wójcik E; Bojarski AJ; Charakchieva-Minol S; Duszyńska B; Nowak G; Maciag D
J Med Chem; 2004 May; 47(10):2659-66. PubMed ID: 15115407
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological evaluation of new 3-[(4-aryl)piperazin-1-yl]-1-arylpropane derivatives as potential antidepressants with a dual mode of action: serotonin reuptake inhibition and 5-HT1A receptor antagonism.
Oficialdegui AM; Martinez J; Pérez S; Heras B; Irurzun M; Palop JA; Tordera R; Lasheras B; del Río J; Monge A
Farmaco; 2000 May; 55(5):345-53. PubMed ID: 10983279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
